Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much has been spent from the public purse on the prescription of drugs to manage Parkinson's disease in each of the last five years.
The Net Ingredient Cost of drugs prescribed and dispensed in primary care under British National Formulary (BNF) section 4.9: Drugs used in parkinsonism and related disorders, split by BNF paragraph for each of the last five years is as follows:
Year | BNF 4.9: Drugs used in parkinsonism and related disorders (£s) | of which | ||
BNF 4.9.1: Dopaminergic drugs used in parkinson’s (£s) | BNF 4.9.2: Antimuscarinic drugs used in parkinsonism (£s) | BNF 4.9.3: Essential tremor, chorea, tics and related disorders (£s) | ||
2013 | 104,719,789 | 94,581,427 | 5,804,699 | 4,333,662 |
2014 | 105,832,050 | 96,847,914 | 6,015,487 | 2,968,648 |
2015 | 111,693,675 | 101,840,937 | 7,230,887 | 2,621,851 |
2016 | 122,804,497 | 103,428,224 | 16,917,632 | 2,458,641 |
2017 | 114,045,034 | 99,357,663 | 12,343,515 | 2,343,856 |
Source: Prescription Cost Analysis